
Tale from the Crypt: Belantamab Mafodotin
OncoPharm
00:00
Belantamab mafodotin: history and mechanism
John Bizarro summarizes the drug's BCMA target, mafodotin payload, and its initial accelerated approval in 2020.
Play episode from 00:39
Transcript


